Article
Publicly Available
Oral therapy of L-glutamic acid γ-monohydroxamate-vanadium (2:1) complex: Improvement of blood glucose profile in different types of diabetic rodents
-
Y. Shechter
Published/Copyright:
January 1, 2009
Published Online: 2009-01-01
Published in Print: 2005-01-01
© 2013 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Preface
- Fifteen years of dancing with vanadium
- Oxovanadium(IV)-sulfite compounds: Synthesis and structural and physical studies
- Selective synthetic methods using vanadium-mediated redox reactions
- Stereoselective syntheses of functionalized cyclic ethers via (Schiff-base)vanadium(V)-catalyzed oxidations
- Sustainable vanadium(V)-catalyzed oxybromination of styrene: Two-phase system versus ionic liquids
- Vanadium(III) binding strengths of small biomolecules
- Synthetic and computational modeling of the vanadium-dependent haloperoxidases
- Modeling the active site structures of vanadate-dependent peroxidases and vanadate-inhibited phosphatases
- Oral therapy of L-glutamic acid γ-monohydroxamate-vanadium (2:1) complex: Improvement of blood glucose profile in different types of diabetic rodents
- New developments of insulinomimetic dinuclear vanadyl(IV)-tartrate complexes
- Postgenomic chemistry (IUPAC Technical Report)
Keywords for this article
alternative pathways;
antidiabetic agents;
Diabetes;
diabetic rodents;
insulinomimetic agents;
vanadium
Articles in the same Issue
- Preface
- Fifteen years of dancing with vanadium
- Oxovanadium(IV)-sulfite compounds: Synthesis and structural and physical studies
- Selective synthetic methods using vanadium-mediated redox reactions
- Stereoselective syntheses of functionalized cyclic ethers via (Schiff-base)vanadium(V)-catalyzed oxidations
- Sustainable vanadium(V)-catalyzed oxybromination of styrene: Two-phase system versus ionic liquids
- Vanadium(III) binding strengths of small biomolecules
- Synthetic and computational modeling of the vanadium-dependent haloperoxidases
- Modeling the active site structures of vanadate-dependent peroxidases and vanadate-inhibited phosphatases
- Oral therapy of L-glutamic acid γ-monohydroxamate-vanadium (2:1) complex: Improvement of blood glucose profile in different types of diabetic rodents
- New developments of insulinomimetic dinuclear vanadyl(IV)-tartrate complexes
- Postgenomic chemistry (IUPAC Technical Report)
